Market Overview
Global Calcipotriol (Calcipotriene) Ointment market size was valued at USD 9,705 million in 2024 and is projected to reach USD 16,210 million by 2031, exhibiting a CAGR of 7.8% during the forecast period. This growth trajectory reflects the increasing demand for effective psoriasis treatments worldwide.
Calcipotriol, also known as calcipotriene, is a synthetic derivative of calcitriol (the active form of vitamin D3) used as a topical treatment for plaque psoriasis. The ointment formulation regulates skin cell production and reduces inflammation, offering patients a non-steroidal therapeutic option. While the global pharmaceutical market grows at 5% CAGR, the calcipotriol segment demonstrates stronger performance due to its established efficacy and expanding applications.
USD 9,705 million in 2024
USD 16,210 million by 2031
of 7.8%
30G/Stick Segment Dominates the Market Due to its Suitability for Prolonged Psoriasis Treatment Regimens
The market is segmented based on type into:
30G/Stick
15G/Stick
By Application
Pharmacy Segment Leads Due to High Accessibility and Direct Consumer Purchase for Ongoing Skin Care Management
The market is segmented based on application into: Hospital Pharmacy Clinic
Other
Portable
Neuromonitoring Device Market
The pharmaceutical sector's expansion underscores the importance of innovations in topical treatments like calcipotriol ointments, which address key challenges such as patient adherence and efficacy. Manufacturers and distributors are focusing on improving formulations to navigate regulatory hurdles and supply chain disruptions, ensuring steady availability for patients worldwide. Key trends include the shift toward over-the-counter options and combination therapies, enhancing market penetration in both developed and emerging regions.
Our Key Players
Huapont (China)
Sinomune Pharma (China)
Bright Future (China)
LEO Pharma (Denmark)
Bidvest Group (South Africa)
Padagis (U.S.)
